Invex Therapeutics Ltd Price (IXC.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

75,312,339

(0.2109)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Perth, Australia. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.059-0.09
  • Market Cap 5.26M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Ms. Narelle Warren B.Com, B.Com., L.L.B., LLB
  • IPO Date: July, 05, 2019
  • Country: AU
  • Currency: AUD
  • Headquaters: Perth, WA
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation